COVID-19: Vaccinated Travel Lane requirements increased

IMPACT – MEDIUM

The Singaporean government has increased requirements for using Vaccinated Travel Lanes (VTLs).

Key Points:

• VTL travelers are now required to quarantine for seven days upon arrival and take a PCR test on day one and six of arrival and ART tests on the following six days.
  • Individuals must take tests for day three and seven at designated facilities; VTL travelers are not required to undergo quarantine.
• As of Jan. 8, non-VTL travelers, such as Work Pass Holder Lane travelers, coming from category 2, 3 or 4 countries no longer need to take a PCR test upon arrival.
  • Travelers from category 1 counties who are not required to quarantine must still take a PCR test upon arrival.
• Authorities have suspended air ticket sales for all VTL countries as well as bus ticket sales for those intending to use the Malaysian VTL. The suspension will remain in place until at least Jan. 20.
  • Beginning Jan. 21, authorities will reduce the quota for ticket sales by half.
  • Travelers who already hold a ticked for a VTL flight or bus can continue to use the VTL scheme.

Additional Information: More information regarding Singapore’s travel health control measures, including country-category lists is available here. Information on the VTL scheme is available here.

BAL Analysis: Due to the increase in Omicron variant cases, travel to Singapore may be more difficult in the coming days and weeks. Health control measures may change with little to no notice. The response to the COVID-19 pandemic continues to develop, and BAL will provide additional updates as information becomes available.

This alert has been provided by the BAL Global Practice group. For additional information, please contact berryapplemanleiden@bal.com.

Copyright © 2022 Berry Appleman & Leiden LLP. All rights reserved. Reprinting or digital redistribution to the public is permitted only with the express written permission of Berry Appleman & Leiden LLP. For inquiries, please contact copyright@bal.com.